1Garmine AA.Tinidazole in anaerobic infections,A review of its antibacterial activity pharmacological properties and fherapeuti efficacy.Drugs,2000,24:85-117
3Ingman T, Tervahartiala T, Ding Y, et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients [J]. Clin Periodontal, 1996, 23 : 1127-1132.
4Reinhardt R A, Stoner J A, Golub L M, et al. Association of gingival crevieular fluid biomarkers during periodontal maintenance with subsequent progressive periodontitis [ J ]. Periodontol, 2010,81 (2) : 251-259.
5Van Lint P, Libert C. Matrix metalloproteinase -8: cleavage can be decisive [ J ]. Cytokine Growth Factor Rev, 2006,17(4) :217 -223.
6Passoja A, Ylipalosaari M, Tervonen T, et al. Matrix metalloproteinase8 concentration in shallow crevices associated with the extent of periodontal disease[J]. Clin Periodontol, 2008,35 (12) : 1027-1031.
7Alfant B, Shaddox L M, Tobler J, et al. Matrix metalloproteinase levels in children with aggressive periodontitis [ J ]. Periodontol, 2008,79 ( 5 ) : 819-826.
8Van Steenberghe D, Rosling B, Soder P o,et al. A 15-month evalution of the effects of repeated subgingvial minocycline in chronic adult periodontitis [ J ]. Periodontol, 1999,70(6) :657-667.
9Meinberg T A, Barnes C M, Duning D G, et al. Comparison of conventional periodontal maintenance versus scaling and root planning with subgingival minocycline [J]. Periodontal, 2002,73:167-172.
